title: Immunomodulation by topical particle-mediated administration of cytokine plasmid DNA suppresses herpetic stromal keratitis without impairment of antiviral defense.
abstract: BACKGROUND
  We investigated whether the course of herpetic stromal keratitis (HSK) in BALB/c mice could be altered by topical gene-gun-mediated administration of interleukin (IL)-4 or IL-10 plasmid DNA.
  
  
  METHODS
  Corneas of BALB/c mice were transfected with plasmids expressing beta-galactosidase (beta-gal), IL-4, IL-10, granulocyte-macrophage colony-stimulating factor (GM-CSF), and pCR3.1 (control) 2 days before Herpes simplex virus-1 (HSV-1; KOS) infection. Development of keratitis and cell infiltration were studied. HSV-1 replication was monitored by plaque assay. Expression of cytokines was detected by enzyme-linked immunosorbent assay. HSV-specific proliferation in the regional lymph nodes and spleens was measured. HSV-1 neutralizing antibody titers and IgG2A/IgG1 ratios were determined.
  
  
  RESULTS
  Expression of beta-gal was found in the treated corneas, but not in other tissues. IL-4 or IL-10 plasmid administration induced cytokine production in the corneas. After treatment with 300 psi, the severity of HSK was attenuated (each P<0.05), and the numbers of infiltrating inflammatory cells were lower than in the pCR3.1-treated controls (P<0.001). IL-6, but not IL-1alpha, expression in the cornea was reduced after treatment with IL-4 or IL-10 plasmid DNA. The HSV-1-specific DTH response, corneal Th1 cytokine profile, IgG/IgG2a/IgG1 ratio, neutralizing antibody titers, and virus clearance did not differ between the groups.
  
  
  CONCLUSIONS
  Thus, topically administered IL-4 and IL-10 plasmid DNA can lead to a milder course of HSK without impeding viral clearance. The gene gun technique for corneal delivery of plasmid cytokine DNA may be useful for modulating local immune responses without affecting antiviral defense.
authors.affiliation: Department of Ophthalmology, Ophtha-Lab at St. Franziskus Hospital, Muenster, Germany. Dirk.Bauer@uveitis-zentrum.de
authors.forename: Dirk
authors.initials: D
authors.lastname: Bauer
authors.forename: Mengji
authors.initials: M
authors.lastname: Lu
authors.forename: Susanne
authors.initials: S
authors.lastname: Wasmuth
authors.forename: Haiping
authors.initials: H
authors.lastname: Li
authors.forename: Yanning
authors.initials: Y
authors.lastname: Yang
authors.forename: Michael
authors.initials: M
authors.lastname: Roggendorf
authors.forename: Klaus Peter
authors.initials: KP
authors.lastname: Steuhl
authors.forename: Arnd
authors.initials: A
authors.lastname: Heiligenhaus
mesh_terms: D000287:Administration, Topical; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood*; D019470:Biolistics; D003315:Cornea / Q000378:metabolism; D003319:Corneal Stroma / Q000821:virology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D015870:Gene Expression; D018259:Herpesvirus 1, Human / Q000502:physiology; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007155:Immunologic Factors; D016753:Interleukin-10 / Q000235:genetics*; D015847:Interleukin-4 / Q000235:genetics*; D016849:Keratitis, Herpetic / Q000235:genetics / Q000276:immunology / Q000517:prevention & control*; D051379:Mice; D008807:Mice, Inbred BALB C; D010957:Plasmids / Q000235:genetics*; D014162:Transfection
chemical_list: D000914:Antibodies, Viral; D007155:Immunologic Factors; D016753:Interleukin-10; D015847:Interleukin-4